The past, present, and future of breast cancer models for nanomedicine development

Even given recent advances in nanomedicine development of breast cancer treatment in recent years and promising results in pre-clinical models, cancer nanomedicines often fail at the clinical trial stage. Limitations of conventional in vitro models include the lack of representation of the stromal p...

Descripción completa

Detalles Bibliográficos
Autores principales: Boix-Montesinos, Paz, Soriano-Teruel, Paula M., Armiñán, Ana, Orzáez, Mar, Vicent, María J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Science Publishers, B.V 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8191594/
https://www.ncbi.nlm.nih.gov/pubmed/33798642
http://dx.doi.org/10.1016/j.addr.2021.03.018

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8191594/
https://www.ncbi.nlm.nih.gov/pubmed/33798642
http://dx.doi.org/10.1016/j.addr.2021.03.018

Ejemplares similares